Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/1995
11/21/1995US5468879 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity
11/21/1995US5468849 Rebeccamycin analogs by tryptophan analogs feeding
11/21/1995US5468769 Antitumor
11/21/1995US5468733 For treating cancer
11/21/1995US5468637 S. lavendofoliae DKRS cell culture producing anti-tumor aclacinomycins A, B, Y and aglycones
11/20/1995EP0690712A4 Taxanes having a pyridyl substituted side-chain
11/16/1995WO1995030900A1 MODULATORS OF CYTOKINES OF THE TGF-β SUPERFAMILY AND METHODS FOR ASSAYING FOR SAME
11/16/1995WO1995030763A2 Retroviral vectors having a reduced recombination rate
11/16/1995WO1995030761A2 Methods of in vivo gene delivery
11/16/1995WO1995030691A1 New peptide active substance and production thereof
11/16/1995WO1995030690A1 Novel tetrapeptides, their manufacture and use
11/16/1995WO1995030687A1 Neurokinine (tachykinine) antagonists
11/16/1995WO1995030673A1 Anti-cancer compounds containing cyclopentaquinazoline ring
11/16/1995WO1995030640A1 Substituted fused and bridged bicyclic compounds as therapeutic agents
11/16/1995WO1995030424A1 O-desulfated heparin derivatives, methods of making and uses thereof
11/16/1995WO1995030415A1 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
11/16/1995DE19516631A1 Ungesättigte Taxan-Verbindungen Unsaturated taxane compounds
11/16/1995CA2189764A1 Neurokinine (tachykinine) antagonists
11/16/1995CA2189452A1 Methods of in vivo gene delivery
11/16/1995CA2189340A1 Modulators of cytokines of the tgf-.beta. superfamily and methods for assaying for same
11/16/1995CA2189336A1 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases
11/16/1995CA2189038A1 O-desulfated heparin derivatives, methods of making and uses thereof
11/16/1995CA2158977A1 Retroviral vectors having a reduced recombination rate
11/15/1995EP0682039A1 CTLA4 molecules and IL4-binding molecules and uses thereof
11/15/1995EP0682027A1 Pyrrolopyrimidine derivatives with antiproliferative action
11/15/1995EP0682017A1 Substituted bicycle heteroaroylguanidines, their preparation and their application in medicaments and diagnostic agents
11/15/1995EP0681835A1 Methods for inhibiting endometriosis and uterine fibroid disease with 1,1,2-triphenylbut-1-ene derivatives
11/15/1995EP0681589A1 Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10
11/15/1995EP0681584A1 Condensed heterocyclic glutamic acid derivatives as antiproliferative agents
11/15/1995EP0681575A1 Process for the preparation of baccatin iii analogs bearing new c2 and c4 functional groups
11/15/1995EP0681574A1 C7 taxane derivatives and pharmaceutical compositions containing them
11/15/1995EP0681573A1 C2 taxane derivatives and pharmaceutical compositions containing them
11/15/1995EP0681484A1 Immunoreactive reagents employing heterodimers
11/15/1995EP0551434B1 High affinity tamoxifen derivatives and uses thereof
11/15/1995EP0491864B1 Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof
11/15/1995EP0444186B1 Pharmaceutical composition that makes cells expressing mhc class ii antigens targets for cytotoxic t-cells
11/15/1995EP0238545B1 C20 through c26 amino steroids
11/15/1995CN1111910A Mammamodulin, a hormone-independent mammary tumor cells specific protein
11/15/1995CN1111637A Phosphonooxymethyl ethers of taxane derivatives
11/15/1995CN1111630A Adhesion receptor antagonists
11/15/1995CN1111618A Urea-subtituted benzoylguanidines, proces for their preparation, their use as pharmaceutical or diagnostic, and pharmaceutical containing them
11/15/1995CN1111508A Fatty acid derivatives
11/14/1995US5466834 Preparation of substituted isoserine esters using metal alkoxides and .beta.
11/14/1995US5466810 Estrogen inhibitors
11/14/1995US5466809 Process for the preparation of immunostimulating swainsonine analogs
11/14/1995US5466678 Potentiating antitumor activity
11/14/1995US5466596 Genetic engineering
11/12/1995CA2149091A1 Methods for inhibiting endometriosis and uterine fibroid disease with 1,1,2-triphenylbut-1-ene derivatives
11/09/1995WO1995030014A1 Bifunctional protein, preparation and use
11/09/1995WO1995030007A1 Thymidine kinase mutants
11/09/1995WO1995030002A2 Enhancing the sensitivity of tumor cells to therapies
11/09/1995WO1995029937A1 A new 78 residue polypeptide (nk-lysine) and its use
11/09/1995WO1995029919A1 Preparation of a camptothecin derivative by intramolecular cyclisation
11/09/1995WO1995029917A2 Intermediates in pharmaceutical camptothecin preparation
11/09/1995WO1995029915A1 Polyethylene glycol derivatised dihydro or tetrahydro porphyrins, their preparation and their use as tumour localising, photosensitising compounds
11/09/1995WO1995029900A1 CONDENSED HETEROCYCLIC COMPOUNDS, THEIR PRODUCTION AND USE AS GnRH ANTAGONISTS
11/09/1995WO1995029895A1 Dihydrodibenzo(de,h)isoquinolines derivatives and their use as anti-cancer agents
11/09/1995WO1995029707A1 Composition for delivery of toxic radioisotopes to the cell nucleus and use
11/09/1995WO1995029706A1 TIN-117m-CONTAINING RADIOTHERAPEUTIC AGENTS
11/09/1995WO1995029702A1 Texaphyrin solid-supports and devices
11/09/1995WO1995029682A1 BINDING OF E-SELECTIN, P-SELECTIN OR L-SELECTIN TO SIALYL-LEWISx OR SIALYL-LEWIS?a¿
11/09/1995WO1995029673A1 Methods for modulating t cell responses by manipulating intracellular signal transduction
11/09/1995WO1995029669A2 Multifunctional ligand for use as a diagnostic or therapeutic pharmaceutical
11/09/1995DE4415998A1 Neue Tetrapeptide, ihre Herstellung Verwendung New tetrapeptides, their preparation using
11/09/1995DE4415997A1 Neuer peptidischer Wirkstoff und dessen Herstellung New peptidic drug and its preparation
11/09/1995CA2189543A1 Thymidine kinase mutants
11/09/1995CA2189435A1 Polyethylene glycol derivatised dihydro or tetrahydro porphyrins, their preparation and their use as tumour localising, photosensitising compounds
11/09/1995CA2189053A1 Condensed heterocyclic compounds, their production and use as gnrh antagonists
11/09/1995CA2189032A1 Enhancing the sensitivity of tumor cells to therapies
11/09/1995CA2189013A1 Binding of e-selectin, p-selectin or l-selectin to sialyl-lewisx or sialyl-lewisa
11/09/1995CA2188833A1 Dihydrodibenzo(de,h)isoquinolines derivatives and their use as anti-cancer agents
11/09/1995CA2188569A1 Multifunctional ligand for use as a diagnostic or therapeutic pharmaceutical
11/08/1995EP0680969A2 Modified oligonucleotides, their preparation and their use
11/08/1995EP0680964A1 NEW PIRROLO 3,2-e]INDOL DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND APPLICATIONS
11/08/1995EP0680758A1 Pharmaceutical compositions containing tamoxifen or analogs and raloxifene or analogs
11/08/1995EP0680489A1 Foldback triplex-forming oligonucleotides
11/08/1995EP0680488A1 2,6-diaminopurine derivatives
11/08/1995EP0680470A1 Diarylalkyl piperidines useful as multi-drug resistant tumor agents.
11/08/1995EP0680365A1 Method of activating photosensitive agents
11/08/1995EP0680338A1 Ganglioside-klh conjugate vaccines with qs-21
11/08/1995EP0680331A1 Recombinant virus immunotherapy
11/08/1995EP0680330A1 Method for identifying and treating individuals bearing cancer cells that express hla-c-clone 10/mage-1
11/08/1995EP0434765B1 Targeting substance-diagnostic/therapeutic agent conjugates having schiff base linkages
11/08/1995CN1111455A Peptide inhibitors of mitogenesis and motorgenesis
11/08/1995CN1111454A Arylidene and heteroarylidene oxindole derivatives as tyrosine kinase inhibitors
11/08/1995CN1111247A Protein kinase C inhibitors
11/08/1995CN1111130A Stable lyophilized thiotepa composition
11/08/1995CN1111127A Inhibition of phosphatidylinositol 3-kinase with wortmannin and analogs thereof
11/07/1995US5464939 Highly purified protein, production and use thereof
11/07/1995US5464936 Compositions for identification of papillomavirus replication inhibitors
11/07/1995US5464935 Peptide inhibitors of selectin binding
11/07/1995US5464872 Sleep disorders
11/07/1995US5464871 Aromatic nitro and nitroso compounds and their metabolites useful as anti-viral and anti-tumor agents
11/07/1995US5464861 2-thioindoles (selenoindoles) and related disulfides (selenides) which inhibit protein tyrosine kinases and which have antitumor properties
11/07/1995US5464841 Use of delta opioid receptor antagonists to treat immunoregulatory disorders
11/07/1995US5464826 Antitumor, anticarcinogenic agents, treatment of herpes
11/07/1995US5464819 Physiologically active peptide having immunoregulatory activities
11/07/1995US5464751 Purified protein or fragment bindable with p185, translation product of neu oncogene; dimer or trimer of protein; screening for mammalian tumor with p185 on tumor cell surfaces by contacting cells with protein, detecting bound protein
11/07/1995CA2012155C Platinum complexes and antitumor agents containing them as an active ingredient
11/07/1995CA1337529C 16-dehydro-vitamin d -derivatives
1 ... 2084 2085 2086 2087 2088 2089 2090 2091 2092 2093 2094 2095 2096 2097 2098 2099 2100 2101 2102 2103 2104 ... 2211